Personalized Medicine in Cancer Treatment: Apoptosis, Autophagy, and Drug Selection
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 915
Special Issue Editor
Special Issue Information
Dear Colleagues,
To examine the ever-changing environment of personalized medicine in cancer treatment using a comprehensive approach, this collection elucidates the complex mechanisms of apoptosis and autophagy, focusing on their crucial significance in customizing cancer treatments for each patient. Moreover, the Special Issue highlights the importance of choosing the appropriate drugs and offers valuable information on the always-improving methods for determining the most efficient therapies based on an individual's specific genetic makeup.
In addition to cancer, the Special Issue also discusses neurological illnesses. The collection provides a thorough examination of the convergence of personalized medicine and neurological health, focusing on specific interventions and novel strategies to address neurodegenerative disorders.
The Special Issue emphasizes natural products (comprising defined molecular compounds) which possess a wide range of medicinal capabilities that are frequently unexplored. The summaries in this Special Issue outline the investigation of nature's pharmacopeia, showcasing studies on utilizing the advantages of natural substances in individualized cancer therapy and other areas.
The collection of papers encompasses advanced research that focuses on the use of personalized medicine in cancer therapy. It explores the roles of apoptosis as well as autophagy, improves drug selection methods, addresses neurodegenerative disorders and reveals the therapeutic benefits of natural products. The combined knowledge and understanding lead to a more detailed and personalized method of healthcare, representing a significant milestone in the pursuit of precision medicine.
Dr. Md Ataur Rahman
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- personalized medicine
- cancer treatment and metabolism
- cell signaling
- apoptosis
- autophagy
- drug target
- neurodegenerative disorders
- natural products
